These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 6119512)
1. Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis. Anders BJ; Lauer BA; Paisley JW; Reller LB Lancet; 1982 Jan; 1(8264):131-2. PubMed ID: 6119512 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Campylobacter-associated enteritis with erythromycin. Robins-Browne RM; Mackenjee MK; Bodasing MN; Coovadia HM Am J Dis Child; 1983 Mar; 137(3):282-5. PubMed ID: 6337473 [TBL] [Abstract][Full Text] [Related]
3. Erythromycin in treatment of Campylobacter enteritis in children. Pai CH; Gillis F; Tuomanen E; Marks MI Am J Dis Child; 1983 Mar; 137(3):286-8. PubMed ID: 6600579 [TBL] [Abstract][Full Text] [Related]
12. Campylobacter jejuni enteritis: efficacy of antimicrobial and antimotility drugs. Nolan CM; Johnson KE; Coyle MB; Faler K Am J Gastroenterol; 1983 Oct; 78(10):621-6. PubMed ID: 6624735 [TBL] [Abstract][Full Text] [Related]
13. Campylobacter: common cause of enteritis in an infectious diseases hospital. Williams GV; Deacon GJ Med J Aust; 1980 Sep; 2(5):268-71. PubMed ID: 7432313 [TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of Campylobacter enteritis after pediatric renal transplantation: A retrospective analysis from single center. Ban H; Miura K; Ishizuka K; Kaneko N; Taniguchi Y; Nagasawa T; Shirai Y; Yabuuchi T; Takagi Y; Goto A; Hattori M Transpl Infect Dis; 2019 Apr; 21(2):e13040. PubMed ID: 30570191 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of clinical efficacy of rokitamycin (RKM) and ofloxacin (OFLX) for the treatment of Campylobacter enteritis by a double-blind method. The Research Committee for the Effect of Rokitamycin, Research Group for Infectious Enteritis]. Obana M; Tomizawa I; Takizawa Y; Nitta Y; Sagara H; Seo T; Sato J; Tsunoda T; Ota S; Machii A Kansenshogaku Zasshi; 1991 Sep; 65(9):1165-82. PubMed ID: 1761896 [TBL] [Abstract][Full Text] [Related]
16. Effects of erythromycin and ciprofloxacin on chronic fecal excretion of Campylobacter species in marmosets. Goodman LJ; Kaplan RL; Petrak RM; Fliegelman RM; Taff D; Walton F; Penner JL; Trenholme GM Antimicrob Agents Chemother; 1986 Feb; 29(2):185-7. PubMed ID: 2940963 [TBL] [Abstract][Full Text] [Related]
17. Experience with the microbiologic diagnosis of Campylobacter enteritis in an office laboratory. Schwartz RH; Bryan C; Rodriguez WJ; Park C; McCoy P Pediatr Infect Dis; 1983; 2(4):298-301. PubMed ID: 6889157 [TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study. Pichler H; Diridl G; Wolf D Eur J Clin Microbiol; 1986 Apr; 5(2):241-3. PubMed ID: 2941290 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of effectiveness of rokitamycin dry syrup in acute enteritis in pediatrics. A comparative study on rokitamycin and fosfomycin dry syrups]. Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Sakata Y; Yamashita F; Suzuki K; Ishii M Jpn J Antibiot; 1990 Feb; 43(2):257-84. PubMed ID: 2194055 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of erythromycin-resistant Campylobacter jejuni in children. Wang SM; Huang FC; Wu CH; Tang KS; Tiao MM J Microbiol Immunol Infect; 2011 Feb; 44(1):63-6. PubMed ID: 21531355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]